What is Cullinan Therapeutics, Inc.'s net investment in lease?

Cullinan Therapeutics, Inc. (CGEM) reported net investment in lease of $2.44M in Q1 2026.

How has Cullinan Therapeutics, Inc.'s net investment in lease changed year-over-year?

Cullinan Therapeutics, Inc.'s net investment in lease increased by 57.2% year-over-year, from $1.55M to $2.44M.

Cullinan Therapeutics, Inc. CGEM Net Investment in Lease

Net Investment in Lease at other companies

Janux TherapeuticsJANX

——

ImmunityBio, Inc.IBRX

——

OmerosOMER

——

Corvus PharmaceuticalsCRVS

——

Vor BiopharmaVOR

——

Avalo TherapeuticsAVTX

——

Other financials

Income statement

See full

Revenue-—

Operating income-$53.7M+2.4%

Net income-$49.7M-2.4%

EPS (diluted)-$0.69+24.2%

Balance sheet

See full

Cash & equivalents$75.1M-2.1%

Total debt$2.4M+29.5%

Total equity$408.7M-30.8%

Total assets$403.0M-30.5%

Cash flow

See full

Operating cash flow-$46.0M-6.7%

CapEx$11.0K—

Free cash flow-$38.1M-4.1%

Valuation

See full

Market cap$1.08B+140%

Enterprise value$1.01B+168%

Profitability

See full

Operating margin-358.7%—

Net margin-346.1%—

Returns & leverage

See full

Return on equity-44%+26.2pp

Debt / equity0×0.0×

Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s net investment in lease?: Cullinan Therapeutics, Inc. (CGEM) reported net investment in lease of $2.44M in Q1 2026.
How has Cullinan Therapeutics, Inc.'s net investment in lease changed year-over-year?: Cullinan Therapeutics, Inc.'s net investment in lease increased by 57.2% year-over-year, from $1.55M to $2.44M.